Older patients taking GlaxoSmithKline P.L.C.'s diabetes drug Avandia had an increased risk of death and heart failure compared with similar patients taking Actos, a competing diabetes drug.

Older patients taking GlaxoSmithKline P.L.C.'s diabetes drug Avandia had an increased risk of death and heart failure compared with similar patients taking Actos, a competing diabetes drug.